In many cases, crucial genes show relatively slight changes between groups of samples (e.g. normal vs. disease), and many genes selected from microarray differential analysis by measuring the expression level statistically are also poorly annotated and lack of biological significance. In this paper, we present an innovative approach -network expansion and pathway enrichment analysis (NEPEA) for integrative microarray analysis. We assume that organized knowledge will help microarray data analysis in significant ways, and the organized knowledge could be represented as molecular interaction networks or biological pathways. Based on this hypothesis, we develop the NEPEA framework based on network expansion from the human annotated and predicted protein interaction (HAPPI) database, and pathway enrichment from the human pathway database (HPD). We use a recently-published microarray dataset (GSE24215) related to insulin resistance and type 2 diabetes (T2D) as case study, since this study provided a thorough experimental validation for both genes and pathways identified computationally from classical microarray analysis and pathway analysis. We perform our NEPEA analysis for this dataset based on the results from the classical microarray analysis to identify biologically significant genes and pathways. Our findings are not only consistent with the original findings mostly, but also obtained more supports from other literatures.
Background
Microarrays make possible the discovery of new functions and pathways of known genes, as they measure all the transcriptional activity in a biological sample [1] . This high-throughput procedure can be used in medical diagnostics, in biomarker discovery, and in investigating the ways a drug, disease, polymorphism or environmental condition affects gene expression and function [2, 3] . However, one challenge has arisen because microarray technology generates a large amount of transcriptional data, which is hard to interpret for the results to gain insights into biological mechanisms [4] . As a result, researchers have sought to analyze microarray data through the use of modern computational tools and statistical methods.
In many cases, crucial genes show relatively slight changes, and many genes selected from differential analysis between groups of samples (e.g. normal vs. disease) by measuring the expression level statistically are also poorly annotated [2] . From a biological perspective, functionally related genes often display a coordinated expression to accomplish their roles in the cell [5] . Hence, to translate such lists of differentially expressed genes into a functional profile able to understand the underlying biological phenomena, one approach to aid interpretation is to look for changes in a group of genes with a common function [2] .
Gene set enrichment analysis (GSEA) is one of the most widely used methods for identifying both statistically and biologically significant genes from high-throughput data such as geneexpression assays [4] . GSEA relies on pre-defined gene sets, while neglect gene/protein interaction, pathway upstream or downstream information. Furthermore, GSEA still assumes that more differentially expressed genes are more crucial to the biology, which is not always true [6] . Currently, gene expression signature analysis and pathway analysis remain two separate processes.
From a view of network biology [7] , cancer genes and proteins do not function in isolation; instead, they work in interconnected pathways and molecular networks at multiple levels [8] , one study re-characterized them in a molecular interaction network for BRCA, and identified HMMR as a new susceptibility locus [9] . Another study integrated protein interaction network and gene expression data to improve the prediction of BRCA metastasis [10] . These works suggest that protein interaction networks and pathways, although noisy, incomplete and static, can serve as a molecular-level conceptual roadmap to guide future microarray analysis [11] .
In this paper, we present an innovative approach -network expansion and pathway enrichment analysis (NEPEA) for integrative microarray analysis. We assume that organized knowledge will help microarray data analysis in significant ways, and the organized knowledge could be represented as molecular interaction networks or biological pathways. Based on this hypothesis, we develop the NEPEA framework based on network expansion [12] from the human annotated and predicted protein interaction (HAPPI) database [13] , and pathway enrichment from the human pathway database (HPD) [14] .
We use a recently-published microarray dataset (GSE24215) related to insulin resistance and type 2 diabetes (T2D) as case study, since this study provided a thorough experimental validation for both genes and pathways identified computationally from classical microarray analysis and pathway analysis [15] . In this study, skeletal muscle samples were collected in all participants (n = 20) in both the basal and insulin-stimulated state before and after bed rest. We perform our NEPEA analysis for this dataset based on the results from the classical microarray analysis to identify biologically significant genes and pathways. Our findings are not only consistent with the original findings mostly, but also obtained more supports from other literatures.
Methods
The NEPEA method has three main components: 1) classical microarray analysis for data preprocessing consisting of quality control, normalization and differential analysis, 2) network expansion analysis for significant gene identification consisting of disease gene curation, network construction and significance score calculation, and 3) pathway enrichment analysis consisting of pathway search, pathway differential analysis and ranking. Using the microarray dataset -GSE24215 as an example, we introduce the detailed steps below:
Microarray data preprocessing

Quality Control
We use AffyQCReport (applicable for Affymetrix platform) and ArrayQualityMetrics (applicable for Agilent platform) packages in Bioconductor to generate three plots to detect bad chips for each microarray dataset as: 1) examine a heat map that shows array-array Spearman rank correlation coefficients. The map enabled us to plot outliers, failed hybridizations, and mis-tracked samples; 2) make a box plot of all perfect match intensities. The plot enabled us to detect outliers in terms of average intensity; and 3) make a distribution plot of kernel density estimates for perfect match intensities, which enables us to detect outliers in terms of shaped density. After applying ArrayQualityMetrics packages into quality control for microarray dataset -GSE24215, total 3 suspects out of 48 samples are flagged, which are kicked off as bad chips.
Normalization
We use Quantile normalization to normalize all the four qualified microarray datasets; MAS5 for Affymetric platform and normexp for Agilent platform on background correction. We also perform the steps background correction, normalization, probe speci fic correction, and summary value computation as following: 1) bgcorrect.method: mas; 2) normalize.method:quantiles; 3) pmcorrect.method:pmonly; and 4) summary.method:mas.
Differential analysis
We use Limma (Linear Models for Microarray Data) package [16] in Bioconductor to identify differentially-expressed genes for each clinical group comparison from the qualified and normalized microarray datasets as 1) The package Limma uses an approach called linear models to analyze designed microarray experiments; 2) For statistical analysis and assessing deferential expression, Limma uses an empirical Bayes method for more stable inference and improved power, especially for experiments with small numbers of arrays; and 3) Differential genes are obtained by using the filters with p-Value <= 0.05, Fold Change (FC) >= 1.3, and Average Expression Level (AEL) >= 40% after applying Limma package in Bioconductor. Average expression levels (AEL>=40%) have been checked to ensure the presences of the differential genes in the tissue -muscle. Duplicated genes with lower fold changes are eliminated, which implies that only the highest fold change for one gene will be kept. For microarray dataset -GSE24215, we get 495 differential genes from insulin before-bed (IBB) group, and 930 differential genes from insulin after-bed (IAB) group
2.2
Network expansion analysis
Disease gene curation
The network expansion analysis is knowledge-guided approach, which relies on the diseaseassociated genes. Here we use T2D as an example to demonstrate how to curate diseaseassociated genes, but our method can be applied to any other disease phenotypes. Results: Records (Entries) -> Genes (Gene Symbol) -> Proteins (Uniprot ID); 3) GENE: Gene name, linked to GeneCards.org; 4) UNIPROT: Uniprot ID, linked to UniProt.org; 5) PUBMED: Count number of references where both term ("Type II Diabetes" OR "Type 2 Diabetes") AND "GENE" appeared in PubMed, linked to PubMed; and 6) Obtain interactions from HAPPI 1.31 for these T2D-associated genes (seed genes) curated from OMIM.
Network reconstruction
We construct a T2D-specific protein-protein interaction (PPI) network by using Oracle SQL Developer with high-quality interaction data in HAPPI version 1.31 and map differentiallyexpressed genes onto the T2D-specific PPI network by using Cytoscape as following: 1) Expand 39 seed genes (PUBMED >=50) in HAPPI 1.31 (4-Star, h-Score >=0.75), and obtain 702 genes (including 32 seed genes); 2) The left 7 seed genes are also added into the network in order to show their expressions; and 3) Construct a T2D-specific PPI network with 709 nodes and 944 edges, by using Nearest Neighbor Expansion (NNE) approach [12] .
Significant gene identification
We measure and rank all the differential genes in a T2D-specific protein-protein interaction (PPI) network by considering both differential expressions and network properties. Differential genes are obtained by applying filters with p-Value <= 0.05, Average Expression Level (AEL) >= 40%, and Absolute Fold Change (ABS_FC) >= 1.3. Duplicated genes with lower fold changes have been eliminated, which implies that only the highest fold change for one gene will be kept. The T2D-specific PPI network is reconstructed by expanding all the seed genes curated from OMIM (PUBMED >=0), in HAPPI_1.31 (3-Star) (Confidence: hScore >=0.45)
We define Gene Significance Score (integrating both gene expression fold change -FC and network connectivity -NC) here as:
Constant parameters α 1 and α 2 here are for the balance between differential expressions and network properties. In the implementation, α 1 =3 and α 2 =1 have best performance to rank known significant genes in the front. Network connectivity (for un-weighted networks) NC: Weight_1 = Number of direct neighbors for each node. Network connectivity (for weighted networks) NC: Weight_2 = Sum of connection strength values on all neighbored edges. In the implementation, we use Weight_2 here. Connection strength here is the confidence for an interaction: h-Score.
Pathway enrichment analysis
Pathway search
We search curated T2D-associated genes by using Oracle SQL Developer with comprehensive integrated pathway data in HPD version 2.1 (including pathway data from NCI-Nature curated, KEGG, BioCarta, and Protein Lounge), and map differentially-expressed genes onto the pathways obtained. We obtain 92 pathways with (HITS/Pathway Scale) >= 3.5% AND HITS >=2 by querying 39 seed genes (PUBMED >=50) in HPD 2.1.
Pathway differential analysis
We provide average differential gene expressions in a pathway as:
AVG_ABS_FC: The average of ABS_FC of all the available differential gene expressions in a pathway.
We define pathway differential expressions here as:
The p*-norm of ABS_FC of all the available differential gene expressions in a pathway
For unification, we modify it as p*-norm = (
In the implementation, p = 6 have best performance to emphasize highly differential expressions in a pathway.
We also provide maximal differential gene expressions in a pathway as:
The maximum value of ABS_FC of all the available differential gene expressions in a pathway;
and count number of differentially expressed genes as:
CNT_DIFF: Count number of differentially expressed genes (FC >= 1.3 AND p-Value <= 0.05) in a pathway.
We rank all the pathways by their pathway differential expressions -NORM_ABS_FC defined above.
Results
Findings on insulin before-bed (IBB) group
Top-20 differential genes
Totally 495 differential genes are obtained, which are differentially-expressed in Insulin Before Bed (IBB) Group from the microarray dataset -GSE24215. Differential genes are obtained by using filters with p-Value <= 0.05, Fold Change (FC) >= 1.3, and Average Expression Level (AEL) >= 40% after applying Limma package in Bioconductor. Average expression levels (AEL>=40%) have been checked to ensure the presences of the differential genes in the tissue -muscle. Duplicated genes with lower fold changes are eliminated, which implies that only the highest fold change for one gene will be kept. Top-20 differential genes in IBB from GSE24215, ordered by absolute fold change (ABS_FC), are listed in Table 1 .
Top-20 significant genes
Totally 130 significant genes in IBB from GSE24215 are obtained from all the differential genes in a T2D-specific protein-protein interaction (PPI) network, measured by using significant score (considering both differential expressions and network properties). The T2D-specific PPI network is reconstructed by expanding all the seed genes curated from OMIM (PubMed >=0), in HAPPI_1.31 (3-Star) (Confidence: h-Score >=0.45). Top-20 significant genes in IBB from GSE24215, ordered by significant score (Sig_Score), are listed in Table 2 .
A T2D-significant protein-protein interaction (PPI) network (See Figure 1) is reconstructed a by connecting Top-20 significant genes in IBB from GSE24215, with and within the T2D-associated genes (seed genes) curated from OMIM (PubMed >= 50), in HAPPI_1.31 (3-Star) (Confidence: h-Score >=0.75). 
Top-20 significant pathways
Totally 51 significant pathways (p*-norm >= 1.2) in IBB from GSE24215 are obtained from all the differential pathways, measured by using pathway differential expressions (p*-norm). Top-20 significant pathways in IBB from GSE24215, ordered by pathway differential expressions (p*-norm), are listed in Table 3 .
Findings on insulin after-bed (IAB) group
Top-20 differential genes
Totally 930 differential genes are obtained, which are differentially-expressed After Bed (IAB) Group from the microarray dataset -GSE24215. Differential genes are obtained by using filters with p-Value <= 0.05, Fold Change (FC) >= 1.3, and Average Expression Level (AEL) >= 40% after applying Limma package in Bioconductor. Average expression levels (AEL>=40%) have been checked to ensure the presences of the differential genes in the tissue -muscle. Duplicated genes with lower fold changes are eliminated, which implies that only the highest fold change for one gene will be kept.
Top-20 differential genes in IAB from GSE24215, ordered by absolute fold change (ABS_FC), are listed in Table 4 . 
Top-20 significant genes
Totally 237 significant genes in IAB from GSE24215 are obtained from all the differential genes in a T2D-specific protein-protein interaction (PPI) network, measured by using significant score (considering both differential expressions and network properties). The T2D-specific PPI network is reconstructed by expanding all the seed genes curated from OMIM (PubMed >=0), in HAPPI_1.31 (3-Star) (Confidence: h-Score >=0.45). Top-20 significant genes in IAB from GSE24215, ordered by significant score (Sig_Score), are listed in Table 5 .
A T2D-significant protein-protein interaction (PPI) network (See Figure 2) is reconstructed a by connecting Top-20 significant genes in IAB from GSE24215, with and within the T2D-associated genes (seed genes) curated from OMIM (PubMed >= 50), in HAPPI_1.31 (3-Star) (Confidence: h-Score >=0.75) 
Top-20 significant pathways
Totally 64 significant pathways (p*-norm >= 1.2) in IAB from GSE24215 are obtained from all the differential pathways, measured by using pathway differential expressions (p*-norm). Top-20 significant pathways in IAB from GSE24215, ordered by pathway differential expressions (p*-norm), are listed in Table 6 .
Discussion
The key finding of the present study on GSE24215 was that bed rest was associated with a paradoxically increased response to insulin of genes involved in acute-phase response and inflammation, including IL-6 signaling, IL-10 signaling, and the ER stress pathway, contrasting the development of severe peripheral insulin resistance of glucose metabolism in young healthy men. The present study demonstrated that 9 days of bed rest induces severe transcriptional changes of genes potentially involved in the pathogenesis of insulin resistance and T2D in skeletal muscle, which might to some extent explain the harmful effect of a sedentary lifestyle on human metabolism. Impaired expression of HK2, VEGFA, NDUFB6, PPARGC1A, and OXPHOS genes in general, as well as a markedly increased expression of RRAD, are among the prime candidates contributing to the development of insulin resistance during bed rest. Our analysis on this microarray dataset also shows that Insulin-stimulation After Bed-rest (IAB) is associated with the same significant genes: VEGFA (Rank: 5), PPARGC1A (Rank: 19), HK2 (Rank: 23), and RRAD (Rank: 29). We also found IAB is associated the same/similar pathways: IL-10 Pathway (Rank: 2) from KEGG database, IL6-mediated signaling events (Rank: 3) from NCI-Nature Curated pathway database, igf-1 signaling pathway (Rank: 6)from BioCarta database, Type II diabetes mellitus (Rank: 7) from KEGG database, Growth Hormone Signaling (Rank: 11) from KEGG database, Insulin signaling pathway (Rank: 19) from KEGG database, Jak-STAT signaling pathway (Rank: 20) from KEGG database, il 6 signaling pathway (Rank: 27) from BioCarta database, and role of erbb2 in signal transduction and oncology (Rank 31) from BioCarta database.
Conclusions
In this paper, we apply both classical microarray analysis (such as differential analysis in Bioconductor) and our knowledge-guided analysis (network expansion analysis and pathway enrichment analysis). From the evidence from literature (PubMed), Top 20 significant genes from our analysis have more supports than Top 20 differential genes from simple differential analysis, in the case study on the microarray dataset -GSE24215. This implies the vitality of our hypothesis on which organized knowledge will help microarray data analysis in significant ways.
For GSE24215 dataset, both of the two networks (shown in Figure 1 and Figure 2 ) consist of two subnetworks. The bigger one includes genes that are highly related to diabetic type 2. Some of genes are shared between before bed network and after bed network, like insulin receptor, peroxisome proliferator-activated receptor gamma and so on. For those shared genes, their expressions are different between these two conditions. We can see from the figure that IRS1, PPARG are under-expressed in after bed condition while IRS2 are underexpressed in before bed condition. Beside those shared molecules, some only show in after bed condition, like PPARGC1A, IDE, IL6R, APP, and PTPN1 while others only show in before bed condition, like CD36, SCARB1, SELP, ICAM1, TNFRSF1A, HSD11B1, and AKT2. The smaller one is relatively small sub-network. Commonly shared gene between before bed and after bed are HNF1A, HNF4A and MYC with similar expression level. Some genes like TCF7L2 only show up in before bed network while GCK, GFPT2, FOXO1, and SIRT1 only show in after bed network.
Another interesting finding is that the molecules which connect the red sub-network and bluesubnetwork are different. In before bed network, SMAD3 play this important role while in after bed network it is FOS that connect these two subnetworks. In fact, FOS and SMAD3 are physically interacting with each other and together Smad3 cooperates with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Finally though IGF1 doesn't show up in the network, yet the IGF1 pathway is highly ranked (refer to pathway analysis part) in the after bed condition.
